These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11245296)

  • 21. Manometric and pH-metric features in gastro-oesophageal reflux disease patients with and without Helicobacter pylori infection.
    Manes G; Esposito P; Lioniello M; Bove A; Mosca S; Balzano A
    Dig Liver Dis; 2000; 32(5):372-7. PubMed ID: 11030180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori and gastroesophageal reflux disease.
    Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2014 Jul; 30(4):402-7. PubMed ID: 24848647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett's--what is the interplay?
    Sharma P
    Gut; 2005 Jun; 54(6):739-40. PubMed ID: 15888772
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical presentation of pneumomediastinum with an unusual oesophageal aetiology.
    Buchmaier BS; Bösch D
    QJM; 2011 Jun; 104(6):535-6. PubMed ID: 20798178
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of cardial or fundic mucosa and Helicobacter pylori in the squamous-columnar mucosa in patients with chronic patological gastroesophageal reflux without intestinal metaplasia comparated with controls].
    Csendes A; Smok G; Christensen H; Rojas J; Burdiles P; Korn O
    Rev Med Chil; 1999 Dec; 127(12):1439-46. PubMed ID: 10835750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease.
    Kountouras J; Zavos C; Polyzos SA; Katsinelos P; Stergiopoulos C
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):123. PubMed ID: 24280804
    [No Abstract]   [Full Text] [Related]  

  • 28. [Barrett's esophagus and Helicobacter pylori].
    Sakata H; Fujimoto K
    Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors and gastric neoplasia.
    Kuipers EJ
    Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review Article: is Helicobacter pylori relevant in the management of reflux disease?
    Dent J
    Aliment Pharmacol Ther; 2001 Jun; 15 Suppl 1():16-21. PubMed ID: 11488657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
    Geboes K; Dekker W; Mulder CJ; Nusteling K;
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1819-26. PubMed ID: 11683696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastro-oesophageal reflux disease: current etiologic, pathogenic and diagnostic aspects.
    Sobrino Faya M; Domínguez Muñoz JE
    Rev Esp Enferm Dig; 2001 Feb; 93(2):115-24. PubMed ID: 11471224
    [No Abstract]   [Full Text] [Related]  

  • 33. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
    Zagari RM; Romano M; Ojetti V; Stockbrugger R; Gullini S; Annibale B; Farinati F; Ierardi E; Maconi G; Rugge M; Calabrese C; Di Mario F; Luzza F; Pretolani S; Savio A; Gasbarrini G; Caselli M
    Dig Liver Dis; 2015 Nov; 47(11):903-12. PubMed ID: 26253555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.
    Malfertheiner P; Peitz U
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i13-20. PubMed ID: 15711003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori: a debated factor in gastroesophageal reflux disease.
    Sharma P
    Dig Dis; 2001; 19(2):127-33. PubMed ID: 11549822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eradication and chronic acid suppression. Advances and pseudo-advances].
    Turi S; Schilling D; Riemann JF
    Internist (Berl); 2004 Nov; 45(11):1305-14. PubMed ID: 15232691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice. Barrett's Esophagus.
    Spechler SJ
    N Engl J Med; 2002 Mar; 346(11):836-42. PubMed ID: 11893796
    [No Abstract]   [Full Text] [Related]  

  • 39. Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.
    O'Connor HJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):117-27. PubMed ID: 10102940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastro-oesophageal reflux disease.
    Fox M; Forgacs I
    BMJ; 2006 Jan; 332(7533):88-93. PubMed ID: 16410582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.